Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AGTC Applied Genetic Technologies (AGTC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Applied Genetic Technologies Stock (NASDAQ:AGTC) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get AGTC alerts:Sign Up Key Stats Today's Range$0.39▼$0.3950-Day Range$0.37▼$0.4252-Week Range$0.23▼$2.83VolumeN/AAverage Volume943,490 shsMarket Capitalization$26.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewApplied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.Read More… We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Applied Genetic Technologies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks2nd Percentile Overall ScoreAGTC MarketRank™: Applied Genetic Technologies scored higher than 2% of companies evaluated by MarketBeat, and ranked 971st out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Applied Genetic Technologies.Read more about Applied Genetic Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Applied Genetic Technologies are expected to decrease in the coming year, from ($0.65) to ($0.92) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied Genetic Technologies is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied Genetic Technologies is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied Genetic Technologies has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for AGTC. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied Genetic Technologies does not currently pay a dividend.Dividend GrowthApplied Genetic Technologies does not have a long track record of dividend growth. Sustainability and ESG3.8 / 5Environmental Score-0.62 Short InterestThere is no current short interest data available for AGTC. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for AGTC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied Genetic Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.10% of the stock of Applied Genetic Technologies is held by insiders.Percentage Held by InstitutionsOnly 22.05% of the stock of Applied Genetic Technologies is held by institutions.Read more about Applied Genetic Technologies' insider trading history. Receive AGTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address AGTC Stock News HeadlinesGreenhouse gains: Cucumbers get a genetic upgrade through innovative pollen techSeptember 18, 2024 | msn.comChinese researchers make genetic breakthrough that could change the future of agriculture: 'Powerful and transformative strategy'July 19, 2024 | msn.comWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…November 2, 2024 | Porter & Company (Ad)Genetic Technologies Limited (GENE)April 28, 2024 | finance.yahoo.comDry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsightApril 22, 2024 | finance.yahoo.comBeacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis PigmentosaFebruary 8, 2024 | finance.yahoo.comMetagenomi Technologies Files for Initial Public OfferingJanuary 5, 2024 | marketwatch.comA new mathematical language for biological networksDecember 18, 2023 | msn.comSee More Headlines AGTC Stock Analysis - Frequently Asked Questions How were Applied Genetic Technologies' earnings last quarter? Applied Genetic Technologies Co. (NASDAQ:AGTC) announced its quarterly earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.05. What other stocks do shareholders of Applied Genetic Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Applied Genetic Technologies investors own include Tesla (TSLA), Meta Platforms (META), NIO (NIO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Viking Therapeutics (VKTX). Company Calendar Last Earnings11/09/2021Today11/02/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:AGTC CUSIPN/A CIK1273636 Webwww.agtc.com Phone(386) 462-2204FaxN/AEmployees83Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-68,940,000.00 Net MarginsN/A Pretax Margin-21,537.54% Return on Equity-192.90% Return on Assets-92.54% Debt Debt-to-Equity Ratio0.39 Current Ratio1.40 Quick Ratio1.40 Sales & Book Value Annual Sales$320,000.00 Price / Sales83.19 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book1.51Miscellaneous Outstanding Shares67,632,000Free Float64,859,000Market Cap$26.62 million OptionableOptionable Beta1.55 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (NASDAQ:AGTC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Genetic Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.